Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 459

1.

Including body composition in MELD scores improves mortality prediction among patients awaiting liver transplantation.

Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yao S, Yagi S, Kamo N, Uemoto S.

Clin Nutr. 2019 Aug 21. pii: S0261-5614(19)33024-9. doi: 10.1016/j.clnu.2019.08.012. [Epub ahead of print]

PMID:
31481263
2.

Impact of Graft Quality and Fluid Overload on Postoperative Massive Ascites After Living Donor Liver Transplantation.

Iwaki K, Yagi S, Morita S, Hamaguchi Y, Masano Y, Yamamoto G, Ogawa E, Nagai K, Kamo N, Hata K, Taura K, Okajima H, Kaido T, Uemoto S.

Transplant Proc. 2019 Jul - Aug;51(6):1779-1784. doi: 10.1016/j.transproceed.2019.03.038. Epub 2019 Jul 10.

PMID:
31301855
3.

Distinct Histopathologic Patterns of Finger Eruptions in Dermatomyositis Based on Myositis-Specific Autoantibody Profiles.

Okiyama N, Yamaguchi Y, Kodera M, Hamaguchi Y, Yokozeki H, Ishiguro N, Fujimoto M.

JAMA Dermatol. 2019 Jul 10. doi: 10.1001/jamadermatol.2019.1668. [Epub ahead of print] No abstract available.

PMID:
31290941
4.

Availability of EuroQol-5-Dimensions-5-Level (EQ-5D-5L) as health-related QOL assessment for Japanese systemic sclerosis patients.

Mugii N, Someya F, Noto S, Hamaguchi Y, Matsushita T, Takehara K.

Mod Rheumatol. 2019 Jul 22:1-6. doi: 10.1080/14397595.2019.1640409. [Epub ahead of print]

PMID:
31269847
5.

CD22 and CD72 cooperatively contribute to the development of the reverse Arthus reaction model.

Nguyen VTH, Matsushita T, Zhao C, Fujimoto M, Takehara K, Tedder TF, Hamaguchi Y.

J Dermatol Sci. 2019 Jul;95(1):36-43. doi: 10.1016/j.jdermsci.2019.06.005. Epub 2019 Jun 20.

PMID:
31262443
6.

Performance evaluation of a line blot assay system for detection of anti-PM-Scl antibody in Japanese patients with systemic sclerosis.

Hamaguchi Y, Kuwana M, Takehara K.

Int J Rheum Dis. 2019 Sep;22(9):1746-1751. doi: 10.1111/1756-185X.13638. Epub 2019 Jun 27.

PMID:
31245910
7.

Human leukocyte antigen in Japanese patients with idiopathic inflammatory myopathy.

Furukawa H, Oka S, Kawasaki A, Hidaka M, Shimada K, Kondo Y, Ihata A, Matsushita T, Matsumoto T, Hashimoto A, Matsumoto I, Komiya A, Kobayashi K, Osada A, Katayama M, Okamoto A, Setoguchi K, Kono H, Hamaguchi Y, Matsui T, Fukui N, Tamura H, Takehara K, Nagaoka S, Sugii S, Sumida T, Tsuchiya N, Tohma S.

Mod Rheumatol. 2019 Jul 18:1-7. doi: 10.1080/14397595.2019.1637593. [Epub ahead of print]

PMID:
31242791
8.

Methylene chain ruler for evaluating the regioselectivity of a substrate-recognising oxidation catalyst.

Teramae S, Kito A, Shingaki T, Hamaguchi Y, Yano Y, Nakayama T, Kobayashi Y, Kato N, Umezawa N, Hisamatsu Y, Nagano T, Higuchi T.

Chem Commun (Camb). 2019 Jul 25;55(58):8378-8381. doi: 10.1039/c9cc03041g. Epub 2019 Jun 24.

PMID:
31233056
9.

[Home Visit Rehabilitation for a Patient with ALS to Improve Social Participation].

Hamaguchi Y, Hakuno A, Saito K, Wakabayashi H.

Gan To Kagaku Ryoho. 2019 May;46(Suppl 1):46-48. Japanese.

PMID:
31189851
10.

Ubr1p-Cup9p-Ptr2p pathway involves in the sensitivity to readthrough compounds negamycin derivatives in budding yeast.

Hamada K, Naito A, Hamaguchi Y, Kanesaki Y, Kasahara K, Taguchi A, Omura N, Hayashi Y, Usui T.

Biosci Biotechnol Biochem. 2019 Oct;83(10):1889-1892. doi: 10.1080/09168451.2019.1625263. Epub 2019 Jun 4.

PMID:
31159660
11.

Combined treatment with DPP-4 inhibitor linagliptin and SGLT2 inhibitor empagliflozin attenuates neointima formation after vascular injury in diabetic mice.

Takahashi H, Nomiyama T, Terawaki Y, Horikawa T, Kawanami T, Hamaguchi Y, Tanaka T, Motonaga R, Fukuda T, Tanabe M, Yanase T.

Biochem Biophys Rep. 2019 Apr 19;18:100640. doi: 10.1016/j.bbrep.2019.100640. eCollection 2019 Jul.

12.

Preoperative Visceral Adiposity and Muscularity Predict Poor Outcomes after Hepatectomy for Hepatocellular Carcinoma.

Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yao S, Yagi S, Kamo N, Seo S, Taura K, Okajima H, Uemoto S.

Liver Cancer. 2019 Mar;8(2):92-109. doi: 10.1159/000488779. Epub 2018 Jun 5.

13.

Estimate of the annual risk of tuberculosis infection in a general population of Japan.

Hamaguchi Y, Nishiura H.

J Theor Biol. 2019 Jul 7;472:1-3. doi: 10.1016/j.jtbi.2019.04.003. Epub 2019 Apr 4. No abstract available.

PMID:
30954505
14.

A case of secondary IgA nephropathy accompanied by psoriasis treated with secukinumab.

Ochi M, Toyama T, Ando M, Sato K, Kamikawa Y, Sagara A, Kitajima S, Hara A, Iwata Y, Sakai N, Shimizu M, Furuichi K, Hamaguchi Y, Kaneko S, Wada T.

CEN Case Rep. 2019 Aug;8(3):200-204. doi: 10.1007/s13730-019-00393-5. Epub 2019 Apr 3.

15.

Significance of preoperative sarcopenia to liver surgery.

Kaido T, Hamaguchi Y, Uemoto S.

Hepatobiliary Surg Nutr. 2019 Feb;8(1):59-62. doi: 10.21037/hbsn.2018.11.05. No abstract available.

16.

Progressive Aortic Calcification as a Complication of Dermatomyositis.

Miyoshi S, Matsumoto T, Kidani T, Sugimoto E, Nakamura Y, Yamamoto T, Kato T, Yamamoto S, Hamada C, Hamaguchi N, Hamaguchi Y, Yamaguchi O.

Circ J. 2019 Aug 23;83(9):1972. doi: 10.1253/circj.CJ-18-1249. Epub 2019 Mar 7. No abstract available.

17.

Regulatory B1a Cells Suppress Melanoma Tumor Immunity via IL-10 Production and Inhibiting T Helper Type 1 Cytokine Production in Tumor-Infiltrating CD8+ T Cells.

Kobayashi T, Oishi K, Okamura A, Maeda S, Komuro A, Hamaguchi Y, Fujimoto M, Takehara K, Matsushita T.

J Invest Dermatol. 2019 Jul;139(7):1535-1544.e1. doi: 10.1016/j.jid.2019.02.016. Epub 2019 Mar 2.

PMID:
30836062
18.

Increased expression levels of FcγRIIB on naïve and double-negative memory B cells in patients with systemic sclerosis.

Yagi-Numata N, Matsushita T, Takehara K, Hamaguchi Y.

Clin Exp Rheumatol. 2019 Jan 17. [Epub ahead of print]

PMID:
30719970
19.

Selective androgen receptor modulator, S42 has anabolic and anti-catabolic effects on cultured myotubes.

Muta Y, Tanaka T, Hamaguchi Y, Hamanoue N, Motonaga R, Tanabe M, Nomiyama T, Nawata H, Yanase T.

Biochem Biophys Rep. 2019 Jan 15;17:177-181. doi: 10.1016/j.bbrep.2019.01.006. eCollection 2019 Mar. Review.

20.

Risk-benefit point of the Model for End-stage Liver Disease score in patients waiting for deceased-donor liver transplantation: A single-center experience.

Iwamura S, Kaido T, Morita S, Miyachi Y, Yao S, Shirai H, Kobayashi A, Hamaguchi Y, Kamo N, Yagi S, Uemoto S.

Hepatol Res. 2019 Jun;49(6):687-694. doi: 10.1111/hepr.13320. Epub 2019 Mar 1.

PMID:
30698359
21.

A case of dermatomyositis with the anti-signal recognition particle antibody that was successfully treated with prednisolone and intravenous immunoglobulin therapy.

Mizumaki K, Maeda S, Ikawa Y, Matsushita T, Takehara K, Hamaguchi Y.

J Dermatol. 2019 Jul;46(7):e251-e253. doi: 10.1111/1346-8138.14790. Epub 2019 Jan 28. No abstract available.

PMID:
30690762
22.

Attenuation of murine sclerodermatous models by the selective S1P1 receptor modulator cenerimod.

Kano M, Kobayashi T, Date M, Tennichi M, Hamaguchi Y, Strasser DS, Takehara K, Matsushita T.

Sci Rep. 2019 Jan 24;9(1):658. doi: 10.1038/s41598-018-37074-9.

23.

Bone mineral density correlates with survival after resection of extrahepatic biliary malignancies.

Yao S, Kaido T, Okumura S, Iwamura S, Miyachi Y, Shirai H, Kobayashi A, Hamaguchi Y, Kamo N, Uozumi R, Yagi S, Uemoto S.

Clin Nutr. 2018 Dec 17. pii: S0261-5614(18)32570-6. doi: 10.1016/j.clnu.2018.12.004. [Epub ahead of print]

PMID:
30595376
24.

Identification of RNA biomarkers for chemical safety screening in neural cells derived from mouse embryonic stem cells using RNA deep sequencing analysis.

Tani H, Matsutani T, Aoki H, Nakamura K, Hamaguchi Y, Nakazato T, Hamada M.

Biochem Biophys Res Commun. 2019 May 14;512(4):641-646. doi: 10.1016/j.bbrc.2018.11.141. Epub 2018 Nov 26.

PMID:
30497775
25.

Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation.

Kamo N, Kaido T, Hamaguchi Y, Okumura S, Kobayashi A, Shirai H, Yao S, Yagi S, Uemoto S.

Clin Nutr. 2018 Sep 28. pii: S0261-5614(18)32457-9. doi: 10.1016/j.clnu.2018.09.019. [Epub ahead of print]

PMID:
30482562
26.

Bone Mineral Density as a Risk Factor for Patients Undergoing Surgery for Hepatocellular Carcinoma.

Miyachi Y, Kaido T, Yao S, Shirai H, Kobayashi A, Hamaguchi Y, Kamo N, Yagi S, Uemoto S.

World J Surg. 2019 Mar;43(3):920-928. doi: 10.1007/s00268-018-4861-x.

PMID:
30465085
27.

A case of juvenile localized scleroderma with anti-topoisomerase I antibody.

Shimizu K, Matsushita T, Takehara K, Hamaguchi Y.

Eur J Dermatol. 2018 Nov 13. doi: 10.1684/ejd.2018.3426. [Epub ahead of print] No abstract available.

PMID:
30442630
28.

Reply to: "Relationship Between Sarcopenic Obesity and Outcomes of Hepatectomy for Hepatocellular Carcinoma".

Kaido T, Kobayashi A, Hamaguchi Y, Yao S, Uemoto S.

Ann Surg. 2018 Dec;268(6):e87. doi: 10.1097/SLA.0000000000002788. No abstract available.

PMID:
30423791
29.

Estimating the annual risk of tuberculosis infection in Japan from interferon-gamma release assay data.

Hamaguchi Y, Yamaguchi T, Nishiura H.

J Theor Biol. 2019 Jan 7;460:125-133. doi: 10.1016/j.jtbi.2018.10.017. Epub 2018 Oct 10.

PMID:
30315813
30.

Periorbital Edema as the Initial Sign of Juvenile Dermatomyositis.

Shimizu M, Inoue N, Mizuta M, Sakakibara Y, Hamaguchi Y, Yachie A.

J Clin Rheumatol. 2018 Sep 17. doi: 10.1097/RHU.0000000000000890. [Epub ahead of print] No abstract available.

PMID:
30234551
31.

Increased interleukin-9 levels in sera, muscle and skin of patients with dermatomyositis.

Oishi K, Matsushita T, Takehara K, Hamaguchi Y.

J Dermatol. 2018 Aug;45(8):1023-1025. doi: 10.1111/1346-8138.14518. No abstract available.

PMID:
30133800
32.

Autoantibody to transcriptional intermediary factor-1β as a myositis-specific antibody: clinical correlation with clinically amyopathic dermatomyositis or dermatomyositis with mild myopathy.

Ueda-Hayakawa I, Hamaguchi Y, Okiyama N, Motegi S, Yamaoka T, Miyake S, Higashi A, Okamoto H, Takehara K, Fujimoto M.

Br J Dermatol. 2019 Apr;180(4):881-887. doi: 10.1111/bjd.17098. Epub 2018 Oct 10.

PMID:
30120913
33.

Angiosarcoma-related pneumohemothorax treated with intrapleural paclitaxel administration and pleurodesis with OK-432.

Oishi K, Kitano T, Mizumaki K, Maeda S, Saito D, Yoshida S, Matsumoto I, Takehara K, Hamaguchi Y.

Eur J Dermatol. 2018 Aug 1;28(4):520-521. doi: 10.1684/ejd.2018.3318. No abstract available.

PMID:
30105988
34.

Etiologies, risk factors, and outcomes of bacterial cholangitis after living donor liver transplantation.

Yao S, Yagi S, Nagao M, Uozumi R, Iida T, Iwamura S, Miyachi Y, Shirai H, Kobayashi A, Okumura S, Hamaguchi Y, Masano Y, Kaido T, Okajima H, Uemoto S.

Eur J Clin Microbiol Infect Dis. 2018 Oct;37(10):1973-1982. doi: 10.1007/s10096-018-3333-4. Epub 2018 Jul 23.

PMID:
30039291
35.

BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance.

Matsushita T, Kobayashi T, Mizumaki K, Kano M, Sawada T, Tennichi M, Okamura A, Hamaguchi Y, Iwakura Y, Hasegawa M, Fujimoto M, Takehara K.

Sci Adv. 2018 Jul 11;4(7):eaas9944. doi: 10.1126/sciadv.aas9944. eCollection 2018 Jul.

36.

GLP-1 Receptor Agonist Exendin-4 Attenuates NR4A Orphan Nuclear Receptor NOR1 Expression in Vascular Smooth Muscle Cells.

Takahashi H, Nomiyama T, Terawaki Y, Kawanami T, Hamaguchi Y, Tanaka T, Tanabe M, Bruemmer D, Yanase T.

J Atheroscler Thromb. 2019 Feb 1;26(2):183-197. doi: 10.5551/jat.43414. Epub 2018 Jun 30.

37.

HMGA1a Induces Alternative Splicing of the Estrogen Receptor-αlpha Gene by Trapping U1 snRNP to an Upstream Pseudo-5' Splice Site.

Ohe K, Miyajima S, Tanaka T, Hamaguchi Y, Harada Y, Horita Y, Beppu Y, Ito F, Yamasaki T, Terai H, Mori M, Murata Y, Tanabe M, Abe I, Ashida K, Kobayashi K, Enjoji M, Nomiyama T, Yanase T, Harada N, Utsumi T, Mayeda A.

Front Mol Biosci. 2018 Jun 8;5:52. doi: 10.3389/fmolb.2018.00052. eCollection 2018.

38.

Is Muscle MELD a More Promising Predictor for Mortality After Living Donor Liver Transplantation?

Badawy A, Kaido T, Hamaguchi Y, Anazawa T, Yagi S, Fukumitsu K, Kamo N, Okajima H, Uemoto S.

Prog Transplant. 2018 Sep;28(3):213-219. doi: 10.1177/1526924818781571. Epub 2018 Jun 14.

PMID:
29902957
39.

Impact of Enteral Nutrition with an Immunomodulating Diet Enriched with Hydrolyzed Whey Peptide on Infection After Liver Transplantation.

Kamo N, Kaido T, Hamaguchi Y, Uozumi R, Okumura S, Kobayashi A, Shirai H, Yagi S, Okajima H, Uemoto S.

World J Surg. 2018 Nov;42(11):3715-3725. doi: 10.1007/s00268-018-4680-0.

PMID:
29785692
40.

HMGA1a induces alternative splicing of estrogen receptor alpha in MCF-7 human breast cancer cells.

Ohe K, Miyajima S, Abe I, Tanaka T, Hamaguchi Y, Harada Y, Horita Y, Beppu Y, Ito F, Yamasaki T, Terai H, Mori M, Murata Y, Tanabe M, Ashida K, Kobayashi K, Enjoji M, Yanase T, Harada N, Utsumi T, Mayeda A.

J Steroid Biochem Mol Biol. 2018 Sep;182:21-26. doi: 10.1016/j.jsbmb.2018.04.007. Epub 2018 Apr 17.

PMID:
29678492
41.

Long-term follow-up of finger passive range of motion in Japanese systemic sclerosis patients treated with self-administered stretching.

Mugii N, Matsushita T, Oohata S, Okita H, Yahata T, Someya F, Hasegawa M, Fujimoto M, Takehara K, Hamaguchi Y.

Mod Rheumatol. 2019 May;29(3):484-490. doi: 10.1080/14397595.2018.1466635. Epub 2018 May 15.

PMID:
29667474
42.

Preoperative Low Muscle Mass and Low Muscle Quality Negatively Impact on Pulmonary Function in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma.

Shirai H, Kaido T, Hamaguchi Y, Kobayashi A, Okumura S, Yao S, Yagi S, Kamo N, Taura K, Okajima H, Uemoto S.

Liver Cancer. 2018 Mar;7(1):76-89. doi: 10.1159/000484487. Epub 2017 Dec 8.

43.

Lung cancer in connective tissue disease-associated interstitial lung disease: clinical features and impact on outcomes.

Watanabe S, Saeki K, Waseda Y, Murata A, Takato H, Ichikawa Y, Yasui M, Kimura H, Hamaguchi Y, Matsushita T, Yamada K, Kawano M, Furuichi K, Wada T, Kasahara K.

J Thorac Dis. 2018 Feb;10(2):799-807. doi: 10.21037/jtd.2017.12.134.

44.

Physiological characterization of leaf and internode after bud break in Japanese indigenous Koshu grape by comparative RNA sequencing analysis.

Enoki S, Hamaguchi Y, Suzuki S, Fujisawa H, Hattori T, Arita K, Yamaguchi C, Mikami M, Nagasaka S, Tanaka K.

PLoS One. 2018 Mar 22;13(3):e0194807. doi: 10.1371/journal.pone.0194807. eCollection 2018.

45.

Proposal for new selection criteria considering pre-transplant muscularity and visceral adiposity in living donor liver transplantation.

Hamaguchi Y, Kaido T, Okumura S, Kobayashi A, Shirai H, Yao S, Yagi S, Kamo N, Okajima H, Uemoto S.

J Cachexia Sarcopenia Muscle. 2018 Apr;9(2):246-254. doi: 10.1002/jcsm.12276. Epub 2018 Feb 17.

46.

Selective Androgen Receptor Modulator S42 Suppresses Prostate Cancer Cell Proliferation.

Kawanami T, Tanaka T, Hamaguchi Y, Nomiyama T, Nawata H, Yanase T.

Endocrinology. 2018 Apr 1;159(4):1774-1792. doi: 10.1210/en.2018-00099.

PMID:
29444261
47.

Impact of a new simplified disability scoring system for adult patients with localized scleroderma.

Okiyama N, Asano Y, Hamaguchi Y, Jinnin M, Motegi SI, Koizumi H, Hasegawa M, Ishikawa O, Sato S, Takehara K, Yamamoto T, Fujimoto M, Ihn H.

J Dermatol. 2018 Apr;45(4):431-435. doi: 10.1111/1346-8138.14214. Epub 2018 Jan 25.

PMID:
29369402
48.

In vitro and in silico characterisation of Lactobacillus paraplantarum D2-1, a starter culture for soymilk fermentation.

Endo A, Sasaki F, Maeno S, Kanesaki Y, Hamaguchi Y, Torres GA, Tomita S, Nakagawa J.

Int J Food Sci Nutr. 2018 Nov;69(7):857-869. doi: 10.1080/09637486.2017.1422701. Epub 2018 Jan 10.

PMID:
29318897
49.

Sarcopenia plays a crucial role in liver transplantation.

Kaido T, Hamaguchi Y, Uemoto S.

Hepatobiliary Surg Nutr. 2017 Dec;6(6):434-436. doi: 10.21037/hbsn.2017.08.05. No abstract available.

50.

Impact of sarcopenic overweight on the outcomes after living donor liver transplantation.

Hammad A, Kaido T, Hamaguchi Y, Okumura S, Kobayashi A, Shirai H, Kamo N, Yagi S, Uemoto S.

Hepatobiliary Surg Nutr. 2017 Dec;6(6):367-378. doi: 10.21037/hbsn.2017.02.02.

Supplemental Content

Loading ...
Support Center